OpenEvidence Soars: AI for Doctors Doubles Valuation to $12 Billion!

business #ai 📝 Blog|Analyzed: Jan 21, 2026 16:32•

Published: Jan 21, 2026 16:25

•

1 min read

•Crunchbase News

Analysis

OpenEvidence is revolutionizing healthcare with its AI platform, providing doctors with an incredible 'brain extender.' The recent $250 million Series D funding and valuation doubling to $12 billion are testaments to its success and promising future in the medical field.

Key Takeaways

•OpenEvidence is an AI platform designed to assist doctors in their work.
•The company's valuation has doubled to $12 billion after a recent funding round.
•The Series D funding round raised $250 million.

Reference / Citation

"OpenEvidence announced Wednesday it has raised $250 million in a Series D funding round that doubled its valuation to $12 billion."

C

Crunchbase NewsJan 21, 2026 16:25

* Cited for critical analysis under Article 32.

AI: Your New Personal Assistant for Everyday Life!

AI's Infrastructure Boom: Plumbing's Unexpected Role!

Related Analysis

OpenAI and Microsoft Evolve Partnership with Exciting New Cloud Flexibility

Apr 28, 2026 01:20

Ineffable Intelligence Raises Massive $1.1B Seed Round to Build AI 'Superlearner'

Apr 28, 2026 01:13

Mastering AI Agents: Exciting Opportunities for IT Managers to Reclaim Control

Apr 28, 2026 01:07

Source: Crunchbase News